Cancer Family

Pancreaticobiliary Neoplasm

Non-malignant1,205 active trials11 approved drugs92 evidence items

NCIt: C223357

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (304)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 126–150 of 304 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Ovarian cancer mimicking pancreatic cancer.
Takafumi Nakagawa, Akihiko Kida, Yuji Hodo et al. · J Med Ultrason (2001) · Sep 15, 2026 · PMID 42745140 · candidate dictionary pubmed
Extrapancreatic extension exhibits tumor size-dependent prognostic impact in pancreatic cancer.
Jun Zhou, Xiaolin Dou, Wei Wei et al. · Sci Rep · Sep 15, 2026 · PMID 42744878 · candidate dictionary pubmed
Inhibiting calreticulin palmitoylation enhances the efficacy of elesclomol-CuCl2 on oxaliplatin-triggered immunogenic cell death in pancreatic cancer.
Zhimiao Zou, Xia Li, Yan Ma et al. · Pharmacol Res · Sep 15, 2026 · PMID 42744192 · candidate dictionary pubmed
Survival After Irreversible Electroporation in Unresectable Locally Advanced Pancreatic Cancer: A Meta-analysis.
Shahab Hajibandeh, Mariam Hussain, Kholoud Abu Taha et al. · J Surg Res · Sep 15, 2026 · PMID 42743900 · candidate dictionary pubmed
"Alkaline-Hammer Strategy" Breaks Acidic and Stromal Barriers to Induce Alkaliptosis and Enhance Immunotherapy in Pancreatic Cancer.
Wei Liu, Yilong Li, Kuo He et al. · Angew Chem Int Ed Engl · Sep 14, 2026 · PMID 42454703 · candidate dictionary pubmed
Age-specific pancreatic cancer risk in Italian CDKN2A families.
Bruna Dalmasso, Eleonora Allavena, Andrea Gambino et al. · Dig Liver Dis · Sep 14, 2026 · PMID 42736102 · candidate dictionary pubmed
The Landmark Series: Mutation-Based Therapy of Pancreatic Cancer.

McKenzie L Schaefer, Susan Tsai, Alex B Blair · Ann Surg Oncol · Sep 12, 2026 · PMID 42732021 · candidate dictionary pubmed

AISP position statement: Standardising biological sample collection and handling for advanced diagnostics and multi-omic analyses in pancreatic cancer.

Paola Cappello, Manuel Gentiluomo, Elisa Giovannetti et al. · Dig Liver Dis · Sep 12, 2026 · PMID 42731958 · candidate dictionary pubmed

CFTR modulation alter pancreatic cancer cell growth and signaling: implications for cancer risk in cystic fibrosis.

Yunxia O'Malley, Henry Keen, Ian M Thornell et al. · J Cyst Fibros · Sep 12, 2026 · PMID 42731950 · candidate dictionary pubmed

Deep learning-based CT model for non-invasive prediction of tertiary lymphoid structures in pancreatic cancer: a multicenter study with prospective validation in an immunochemotherapy cohort.

Haopeng Yu, Xiaoying Li, Xuan Cheng et al. · J Immunother Cancer · Sep 12, 2026 · PMID 42731878 · candidate dictionary pubmed

Lack of tumor-derived LCN2 sensitizes pancreatic cancer cells to ferroptosis induction.

Valentina Pita-Grisanti, Kristyn Gumpper-Fedus, Claire Cornellier et al. · Cancer Lett · Sep 12, 2026 · PMID 42731587 · candidate dictionary pubmed

Overcoming cancer resistance in pancreatic cancer: toward dynamic precision oncology.

Takehiro Okabayashi, Motoyasu Tabuchi, Teppei Tokumaru et al. · Mol Biol Rep · Sep 12, 2026 · PMID 42730833 · candidate dictionary pubmed

Reply to: Regarding: Nachira D, Calabrese G, Bertolaccini L, et al. Oncological outcomes and prognostic factors of pulmonary metastasectomy in pancreatic cancer.

Dania Nachira, Giuseppe Calabrese, Luca Bertolaccini et al. · Updates Surg · Sep 11, 2026 · PMID 42726460 · candidate dictionary pubmed

Propionyl-CoA catabolism is a metabolic gatekeeper for fatty acid oxidation in pancreatic cancer.

Weidong Yu, Bo Wang, Fanhao Meng et al. · Oncogene · Sep 11, 2026 · PMID 42728345 · candidate dictionary pubmed

RE: Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysis.

Jiayong Ning, Zhijian Ren, Peng Yao · J Natl Cancer Inst · Sep 11, 2026 · PMID 42728619 · candidate dictionary pubmed

Should Artificial Intelligence Direct Systemic Therapy Decisions in Pancreatic Cancer?

Gabriel A Brooks, Raghav Sundar · J Clin Oncol · Sep 10, 2026 · PMID 42561185 · candidate dictionary pubmed

Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic Cancer.

Audrey Beaufils, Julien De Martino, Xiaofeng Jiang et al. · J Clin Oncol · Sep 10, 2026 · PMID 42507965 · candidate dictionary pubmed

Spatial transcriptome profiling links SERPINA3 to nerve-associated immunosuppression in pancreatic cancer.

Bihan Liu, Yuankang Yang, Yuxi Zhang et al. · Biochem Biophys Res Commun · Sep 10, 2026 · PMID 42442087 · candidate dictionary pubmed

Development and Validation of a Computational Histology Artificial Intelligence-Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic Cancer.

Andrew E Hendifar, Viswesh Krishna, Vrishab Krishna et al. · J Clin Oncol · Sep 10, 2026 · PMID 41671529 · candidate dictionary pubmed

Biomarker discovery and patient stratification in pancreatic cancer using incomplete multi-omics data.

Alejandra Paja-García, Rafael Romero-Becerra, Tero Aittokallio et al. · PLoS Comput Biol · Sep 10, 2026 · PMID 42721202 · candidate dictionary pubmed

Safety and Diagnostic Performance of Pancreatic Duct Brushings for Detecting Pancreatic Cancer.

Shuji Mitsuhashi, Chinmay Guralwar, Jad P AbiMansour et al. · Pancreas · Sep 10, 2026 · PMID 42720991 · candidate dictionary pubmed

Small-Molecule Activators of PRMT1: Discovery, SAR Analyses, and Proapoptotic Effects in Pancreatic Cancer Cells.

Sepideh Salehipour-Bavarsad, Christian Iking, Jonas Kammertöns et al. · J Med Chem · Sep 10, 2026 · PMID 42720487 · candidate dictionary pubmed

Baseline cellular state shapes the molecular impact of mutant KRAS alleles in reconstituted pancreatic cancer cells.

Yanixa Quiñones-Avilés, Barbora Salovska, Cassandra S Markham et al. · Mol Omics · Sep 10, 2026 · PMID 42720273 · candidate dictionary pubmed

Redox-responsive polymeric nanocarriers for targeted delivery of bruceantin to pancreatic cancer.

Yitayal Admassu Workie, Kongbrailatpam Shitaljit Sharma, Vladislav Grigoriev et al. · Nanoscale · Sep 10, 2026 · PMID 42560346 · candidate dictionary pubmed

SUMOylated Reptin maintains low intracellular ROS levels by activating mitophagy to drive gemcitabine resistance in gallbladder cancer.

Chuanxin Yang, Wei Wang, Yaodi Shao et al. · Cell Death Dis · Sep 10, 2026 · PMID 42716921 · candidate dictionary pubmed